NCT02180477View on ClinicalTrials.gov

Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

December 31, 2001

Conditions
Healthy
Interventions
DRUG

UHAC 62 XX - TF1 tablet

DRUG

UHAC 62 XX - TF2 tablet

DRUG

UHAC 62 XX - capsules

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02180477 - Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter